Search Results - "Trevino, Jose G"
-
1
The Current Treatment Paradigm for Pancreatic Ductal Adenocarcinoma and Barriers to Therapeutic Efficacy
Published in Frontiers in oncology (15-07-2021)“…Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, with a median survival time of 10-12 months. Clinically, these poor outcomes are attributed to…”
Get full text
Journal Article -
2
The Microbiota and Cancer Cachexia
Published in International journal of molecular sciences (12-12-2019)“…Cancer cachexia is a multifactorial syndrome defined by weight loss, muscle wasting, and systemic inflammation. It affects the majority of patients with…”
Get full text
Journal Article -
3
Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination Immunotherapy
Published in Cancer research (Chicago, Ill.) (01-08-2020)“…Pancreatic ductal adenocarcinoma (PDAC) is a leading cause of cancer-related death with a median survival time of 6-12 months. Most patients present with…”
Get full text
Journal Article -
4
A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR
Published in Neoplasia (New York, N.Y.) (01-01-2025)“…•Oncogenic KRAS, the key driver for PDAC, currently lacks effective targeting therapy.•Triple inhibition of MEK, BCL-xL and EGFR showed enhanced tumor…”
Get full text
Journal Article -
5
Patient-Derived Xenograft Models for Pancreatic Adenocarcinoma Demonstrate Retention of Tumor Morphology through Incorporation of Murine Stromal Elements
Published in The American journal of pathology (01-05-2015)“…Direct implantation of viable surgical specimens provides a representative preclinical platform in pancreatic adenocarcinoma. Patient-derived xenografts…”
Get full text
Journal Article -
6
Transcriptomic analysis of pancreatic adenocarcinoma specimens obtained from Black and White patients
Published in PloS one (22-02-2023)“…In pancreatic cancer clinical trials, Black patients are under-represented while having higher morbidity and mortality rates as compared to other racial…”
Get full text
Journal Article -
7
Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer
Published in PloS one (12-02-2024)“…Pancreatic ductal adenocarcinomas (PDAC) have heterogeneous tumor microenvironments relatively devoid of infiltrating immune cells. We aimed to quantitatively…”
Get full text
Journal Article -
8
Nicotine Induces Inhibitor of Differentiation-1 in a Src-dependent Pathway Promoting Metastasis and Chemoresistance in Pancreatic Adenocarcinoma
Published in Neoplasia (New York, N.Y.) (01-12-2012)“…Smoking is a significant risk factor for pancreatic cancer, but the molecular mechanisms by which tobacco smoke components promote the growth and progression…”
Get full text
Journal Article -
9
c-Met signaling in the development of tumorigenesis and chemoresistance: Potential applications in pancreatic cancer
Published in World journal of gastroenterology : WJG (14-07-2014)“…Pancreatic ductal adenocarcinoma is the 4th leading cause of cancer deaths in the United States.The majority of patients are candidates only for palliative…”
Get full text
Journal Article -
10
Mas Receptor Activation Slows Tumor Growth and Attenuates Muscle Wasting in Cancer
Published in Cancer research (Chicago, Ill.) (15-02-2019)“…Cancer cachexia is a multifactorial syndrome characterized by a progressive loss of skeletal muscle mass associated with significant functional impairment…”
Get full text
Journal Article -
11
The oral microbiome, pancreatic cancer and human diversity in the age of precision medicine
Published in Microbiome (15-06-2022)“…Pancreatic cancer is a deadly disease with limited diagnostic and treatment options. Not all populations are affected equally, as disparities exist in…”
Get full text
Journal Article -
12
Development of apratoxin S10 (Apra S10) as an anti-pancreatic cancer agent and its preliminary evaluation in an orthotopic patient-derived xenograft (PDX) model
Published in Investigational new drugs (01-04-2019)“…Summary Despite the significant progress in the field of cancer therapeutics, the incidence of pancreatic cancer (PC) has continuously increased. One possible…”
Get full text
Journal Article -
13
Loss of SMAD4 Is Associated With Poor Tumor Immunogenicity and Reduced PD-L1 Expression in Pancreatic Cancer
Published in Frontiers in oncology (28-01-2022)“…Transforming Growth Factor β (TGFβ) is a key mediator of immune evasion in pancreatic ductal adenocarcinoma (PDAC), and the addition of TGFβ inhibitors in…”
Get full text
Journal Article -
14
Oncologic and Perioperative Outcomes Following Selective Application of Laparoscopic Pancreaticoduodenectomy for Periampullary Malignancies
Published in Journal of gastrointestinal surgery (01-07-2016)“…Background Data are sparse regarding patient selection criteria or evaluating oncologic outcomes following laparoscopic pancreaticoduodenectomy (LPD). Having…”
Get full text
Journal Article -
15
Linc-ing Circulating Long Non-coding RNAs to the Diagnosis and Malignant Prediction of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Published in Scientific reports (05-09-2017)“…Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease that lacks effective biomarkers for early detection. We hypothesized that circulating long…”
Get full text
Journal Article -
16
Disconnected Pancreatic Duct Syndrome: Disease Classification and Management Strategies
Published in Journal of the American College of Surgeons (01-10-2014)“…Background Disconnected pancreatic duct syndrome (DPDS) typically complicates acute necrotizing pancreatitis (ANP) and presents as a pseudocyst months after…”
Get full text
Journal Article -
17
FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness
Published in Journal of cachexia, sarcopenia and muscle (01-04-2021)“…Background Skeletal muscle wasting is a devastating consequence of cancer that affects up to 80% of cancer patients and associates with reduced survival…”
Get full text
Journal Article -
18
A clinically applicable muscular index predicts long-term survival in resectable pancreatic cancer
Published in Surgery (01-04-2017)“…Background The relationship between myopenia, nutritional status, and long-term oncologic outcomes remains poorly characterized in patients with clinically…”
Get full text
Journal Article -
19
Distinct cachexia profiles in response to human pancreatic tumours in mouse limb and respiratory muscle
Published in Journal of cachexia, sarcopenia and muscle (01-06-2020)“…Background Cancer cachexia is a life‐threatening metabolic syndrome that causes significant loss of skeletal muscle mass and significantly increases mortality…”
Get full text
Journal Article -
20
Human Norovirus Triggers Primary B Cell Immune Activation In Vitro
Published in mBio (26-04-2022)“…Human norovirus (HNoV) is a global health and socioeconomic burden, estimated to infect every individual at least five times during their lifetime. The…”
Get full text
Journal Article